SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001088856-16-000011
Filing Date
2016-03-10
Accepted
2016-03-10 16:08:17
Documents
65
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cort-20151231x10k.htm 10-K 2002913
2 EX-23.1 cort-20151231xex231.htm EX-23.1 10867
3 EX-31.1 cort-20151231xex311.htm EX-31.1 17110
4 EX-31.2 cort-20151231xex312.htm EX-31.2 17248
5 EX-32.1 cort-20151231xex321.htm EX-32.1 9227
6 EX-32.2 cort-20151231xex322.htm EX-32.2 9450
7 GRAPHIC cort-20151231x10kg001.jpg GRAPHIC 30692
  Complete submission text file 0001088856-16-000011.txt   6893083

Data Files

Seq Description Document Type Size
8 EX-101.INS cort-20151231.xml EX-101.INS 1456389
9 EX-101.SCH cort-20151231.xsd EX-101.SCH 41593
10 EX-101.CAL cort-20151231_cal.xml EX-101.CAL 46955
11 EX-101.DEF cort-20151231_def.xml EX-101.DEF 122946
12 EX-101.LAB cort-20151231_lab.xml EX-101.LAB 360017
13 EX-101.PRE cort-20151231_pre.xml EX-101.PRE 290761
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50679 | Film No.: 161497865
SIC: 2834 Pharmaceutical Preparations